Platelet PGDprime Test
Detection of bacterial contamination in platelets for transfusion
ApprovedActive
Key Facts
Indication
Detection of bacterial contamination in platelets for transfusion
Phase
Approved
Status
Active
Company
About Verax Biomedical
Verax Biomedical is a venture-backed diagnostics company addressing the significant risk of bacterial contamination in platelet transfusions. Its core technology, the Pan Genera Detection (PGD) platform, enables rapid, near-patient testing that has received FDA clearance to extend platelet shelf life to seven days, improving safety, availability, and cost-efficiency for blood centers and hospitals. The company is led by a seasoned management team and supported by a distinguished Medical Advisory Committee, positioning it as a key player in responding to evolving FDA guidance on bacterial risk mitigation in the blood supply.
View full company profile